Vabysmo: The Latest Injectable Treatment for Macular Degeneration

There is a new injectable drug treating both types of macular degeneration offering a more flexible dosing regimen than present medications. Vabysmo has recently been approved by the Food and Drug Administration (FDA). This is a new and effective treatment for macular degeneration, an eye disease causing vision loss.

Living with Macular Degeneration

Macular degeneration has no early symptoms, may be painless, and goes undiagnosed for too long when people are not well-informed about this leading eye disease. By the time macular degeneration is detected by a medical professional, it can have become well advanced.

There are two macular degeneration conditions that cause vision loss:

  • Age-related macular degeneration (AMD)
  • Diabetic macular edema (DME)

The FDA approval, and introduction of Vabysmo to the market, is welcome news for those living with AMD or DME.

Age-Related Macular Degeneration Symptoms

AMD is a condition describing a physical disturbance in the center of your retina – the macula. AMD is one of the leading causes of low vision or loss of eyesight in people over 50.

Wet-AMD symptoms include:

  • Bleeding
  • Leaking
  • Scarring
  • Growth of abnormal blood vessels behind the retina

AMD attacks the central vision and makes you unable to see sharp details.

Diabetic Macular Edema

DME causes blood vessels in the walls of the retina to weaken and form bulging pouches, resulting in the loss of central vision.

DME symptoms include:

  • Leaking blood
  • Leaking fluids
  • Swelling of the retina

Macular Degeneration Treatment

Vabysmo targets dual Ang-2/VEGF-A, the two pathways believed to be responsible for vision loss. When these routs are blocked, Vabysmo reduces the leakage and inflammation of blood vessels. The main benefit of Vabysmo treatment is that it requires fewer injections less frequently than other similar medications.

Protect Your Vision From Macular Degeneration

Regular eye examinations are the most proactive method of protecting your vision from macular degeneration. However, when a drastic change in your vision occurs between regular appointments, you should seek medical attention immediately. If you are symptomatic of macular degeneration, don’t procrastinate. Call 209-952-3700 and reach out to the Central Valley Eye Medical Group today. One of our experienced, board-certified ophthalmologists serving the communities of Stockton, Manteca, or Modesto, CA, can help.

Contact us for more information

*All indicated fields must be completed.
Please include non-medical questions and correspondence only.

Stockton

Central Valley Eye Medical Group (Stockton)

Toll-Free Number: 800-244-9907
Optical Department: 209-477-5578
Fax: 209-952-0553

Monday - Friday: 8:00am – 12:00pm, 1:00pm – 5:00pm

Manteca

Central Valley Eye Medical Group (Manteca)

Toll-Free Number: 800-244-9907
Optical Department: 209-239-0753
Fax: 209-239-0090

Monday - Friday: 8:00am – 12:00pm, 1:00pm – 5:00pm

Modesto

Central Valley Eye Medical Group (Modesto)

Fax: 209-579-1407

Monday - Friday: 8:00am – 12:00pm, 1:00pm – 5:00pm

Valley Laser & Surgery Center

Central Valley Eye Medical Group (Surgery Center)

Fax: 209-952-1174

Monday – Friday: 7:00am – 5:00pm

Accessibility Toolbar